CRO Stocks Extend Gains as Wanbang Pharmaceutical Hits 20% Limit Up

On September 14, 2026, CRO-related shares continued to advance.

As of the time of publication, Wanbang Pharmaceutical hit the 20% limit up, while Yaokang Biotechnology, PharmaBlock Sciences, Sino Biological and other stocks followed with gains.